NEW ENTERPRISE ASSOCIATES 16, L.P. / MIRUM PHARMACEUTICALS, INC. -- SCHEDULE 13D

Company

Mirum Pharmaceuticals, Inc.

Filed

December 29, 2023

Accession Number

0001072613-23-000635